Teikyo University Hospital | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity	Arterial Occlusive Diseases, Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, atherosclerotic cardiovascular disease, cardiovascular disorder, nutritional disorder, obesity disorder, overnutrition, vascular disorder	Recruiting	Phase 3	2026-10-08		NCT07037433
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib	Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypotrichosis, skin disorder	Active, not recruiting	Not stated	2026-10-06		NCT06531109
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis	Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder	Recruiting	Phase 3	2026-08-18		NCT04772079
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis	Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis	Active, not recruiting	Phase 3	2026-07-09		NCT03950232
A Clinical Evaluation of AMJ-401	cardiovascular disorder, heart disorder, myocardial ischemia, vascular disorder	Recruiting	Not applicable	2026-04-07		NCT07373353
Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure	Aspirin; High Bleeding Risk; Left Atrial Appendage Closure; Non-Antithrombotic Therapy; Nonvalvular Atrial Fibrillation	Recruiting	Phase 4	2025-08-15		NCT07125417